11-LUN-87-BMS: (CA184156) Study comparing Ipilimumab plus Etoposide/Platinum versus Etoposide/Platinum

Grants and Contracts Details

StatusFinished
Effective start/end date10/7/12 → 9/30/17

Funding

  • Bristol Myers Squibb Company: $87,833.00